000 | 01597 a2200409 4500 | ||
---|---|---|---|
005 | 20250513222930.0 | ||
264 | 0 | _c20001121 | |
008 | 200011s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLouch, W E | |
245 | 0 | 0 |
_aLosartan improves recovery of contraction and inhibits transient inward current in a cellular model of cardiac ischemia and reperfusion. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cNov 2000 |
||
300 |
_a697-704 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiotensin II _xpharmacology |
650 | 0 | 4 | _aAngiotensin Receptor Antagonists |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
650 | 0 | 4 |
_aCalcium Channels, L-Type _xphysiology |
650 | 0 | 4 |
_aCalcium Channels, T-Type _xphysiology |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aHeart Ventricles _xcytology |
650 | 0 | 4 |
_aLosartan _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aMyocardial Ischemia _xdrug therapy |
650 | 0 | 4 | _aMyocardial Reperfusion |
650 | 0 | 4 |
_aMyocardial Stunning _xdrug therapy |
650 | 0 | 4 | _aPatch-Clamp Techniques |
650 | 0 | 4 | _aReceptor, Angiotensin, Type 1 |
650 | 0 | 4 | _aReceptor, Angiotensin, Type 2 |
700 | 1 | _aFerrier, G R | |
700 | 1 | _aHowlett, S E | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 295 _gno. 2 _gp. 697-704 |
|
999 |
_c10991076 _d10991076 |